The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Companies / S•••••••• T••••••••• I•••

S•••••••• T••••••••• I•••

Stage unknownMedford, MAs••••••••.bioPharmaceuticals

Clinical-stage biotech discovering novel CNS therapies from natural compounds validated by millennia of human use. Anxiety, epilepsy, Alzheimer's.

Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Jan 28, 2025
    Form D equity offering · $14.5M (form d sold) · 4 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “S•••••••• T••••••••• I••• filed Form D: $14,496,526 sold of $38,496,525, Pharmaceuticals”
Investors on record
2 edges
People
2 officers, 7 directors
Timeline
2
  1. Jul 15, 2025
    S•••••••• T••••••••• I••• filed Form D/A: $26,763,207 sold of $58,496,525, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Feb 12, 2025
    S•••••••• T••••••••• I••• filed Form D: $14,496,526 sold of $38,496,525, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
37 observations
Every observation on this company